SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-000923
Filing Date
2022-02-10
Accepted
2022-02-10 07:05:09
Documents
2
Period of Report
2022-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_020922.htm 6-K 4506
2 PRESS RELEASE exh_991.htm EX-99.1 3363
  Complete submission text file 0001171843-22-000923.txt   8856
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 22609544
SIC: 2834 Pharmaceutical Preparations